Clinical Trials · NCT05920889
Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke Treated by Reperfusion Therapies
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Chinese University of Hong Kong
- Enrollment
- 140
- Start date
- Aug 2023
- Locations
- 2 sites, China, Hong Kong
- Primary endpoint
- Change of Modified Rankin Score